Vigil Neuroscience Launches ALSPAware to Provide Access to No-cost Genetic Testing and Counseling for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)

– New genetic testing initiative designed to enable improved patient diagnosis of ALSP, a devastating, rare genetic neurodegenerative disease – – Through ALSPAware, individuals and... | May 8, 2023

Related Keywords

Japan ,Wisconsin ,United States ,Marshfield ,Watertown ,Sarah Carmody ,Ivana Magov ,Megan Mcgrath ,Sister Hope Foundation ,Sciences Corp ,Hunter Hope Foundation ,Nasdaq ,Vigil Neuroscience Inc ,United Leukodystrophy Foundation ,Sciences Company ,Exchange Commission ,Clinical Laboratory Improvement Amendments ,International Organization For Standardization ,Exact Sciences Company ,Chief Executive Officer ,Hope Foundation ,Investigational New Drug Application ,Exact Sciences Corp ,International Organization ,Vigil Neuroscience ,Annual Report ,Nc Stock Exchange ,News ,Information ,Press Release ,Few ,Enetic ,Testing ,Initiative ,Esigned ,O ,Nable ,Mproved ,Patient ,Diagnosis ,F ,Mare ,Neurodegenerative ,Disease ,Through ,Ndividuals Vigl Us92673k1088 ,